JP2003212765A - 水虫の活動を停止させる溶液 - Google Patents

水虫の活動を停止させる溶液

Info

Publication number
JP2003212765A
JP2003212765A JP2002042337A JP2002042337A JP2003212765A JP 2003212765 A JP2003212765 A JP 2003212765A JP 2002042337 A JP2002042337 A JP 2002042337A JP 2002042337 A JP2002042337 A JP 2002042337A JP 2003212765 A JP2003212765 A JP 2003212765A
Authority
JP
Japan
Prior art keywords
foot
athlete
copper
solution
symptom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002042337A
Other languages
English (en)
Inventor
Tadashi Igarashi
正 五十嵐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2002042337A priority Critical patent/JP2003212765A/ja
Publication of JP2003212765A publication Critical patent/JP2003212765A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

(57)【要約】 【課題】 水虫は治癒しにくい病気でありますが、特殊
な薬剤を用いずに、水虫の活動を停止させ、水虫の新た
な感染を防ぐ方法。 【解決手段】酢に銅を浸し、酢の中に銅が溶け出した溶
液を、水虫に感染した足に塗ることによって、水虫の活
動を停止させ、水虫に感染していることを感じさせなく
なる。水虫に感染した皮膚を、白く浮き上がらせたり、
剥けやすくしたりの働きもする。健康な足に塗っておけ
ば、水虫の新たな感染を防ぐことができる

Description

【発明の詳細な説明】 【０００１】 【産業上の利用分野】この発明は、酢に銅を浸し、酢の
中に銅が溶けだした溶液を、足に塗って、用いるもので
ある。 【０００２】 【従来の技術】従来用いられていたのは、薬であって、
日常品の簡便さがなかった。 【０００３】 【発明が解決しようする課題】本発明は、薬という専門
的なものから、手軽に使用できるものを目指した。 【０００４】 【課題を解決するための手段】薬に頼らないで、問題を
解決しょうとすると、身近にある日常的なものでなけれ
ばと考えついたのが 酢と銅との組み合わせである。 【０００５】 【作用】本発明は以上の構成であるから、薬のように水
虫を治癒させるものではないが、薬を使用した時と同じ
ように水虫の活動を停止させることができる。 【０００６】 【実施例】本発明を実施するために、実際に足に塗って
実験をしてみると、数日で水虫の活動が停止した。水虫
薬と本発明品を併用しても副作用は見られなかった併用
することによって、角質に軟化が見られ、角質が落とし
やすくなるという現象も見られた。 【０００７】 【発明の効果】水虫は、薬を使用しても繰り返し発病す
るほど、治癒させることが難しい一面を持っている。本
発明は原材料が安価な酢と銅との単純な構成であるか
ら、経済的な節約効果となる。

Claims (1)

  1. 【特許請求の範囲】 【請求項１】酢に銅を浸し、酢の中に銅が溶け出した溶
    液。
JP2002042337A 2002-01-16 2002-01-16 水虫の活動を停止させる溶液 Pending JP2003212765A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002042337A JP2003212765A (ja) 2002-01-16 2002-01-16 水虫の活動を停止させる溶液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002042337A JP2003212765A (ja) 2002-01-16 2002-01-16 水虫の活動を停止させる溶液

Publications (1)

Publication Number Publication Date
JP2003212765A true JP2003212765A (ja) 2003-07-30

Family

ID=27655213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002042337A Pending JP2003212765A (ja) 2002-01-16 2002-01-16 水虫の活動を停止させる溶液

Country Status (1)

Country Link
JP (1) JP2003212765A (ja)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014150719A1 (en) 2013-03-15 2014-09-25 Cda Research Group, Inc. Topical copper ion treatments in the dermatological areas of the body
CN105407886A (zh) * 2013-03-15 2016-03-16 Cda研究集团股份有限公司 局部铜离子治疗物以及制备用于身体不同解剖区域中的局部铜离子治疗物的方法
WO2018152614A1 (en) * 2017-02-21 2018-08-30 Fine Cotton Factory Inc. Articles for treating concussion and other disorders
US10813948B2 (en) 2013-03-15 2020-10-27 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11253544B2 (en) 2013-03-15 2022-02-22 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
EP3003046A4 (en) * 2013-03-15 2017-03-29 CDA Research Group, Inc. Topical copper ion treatments in the dermatological areas of the body
EP3744176A1 (en) * 2013-03-15 2020-12-02 CDA Research Group, Inc. Topical copper ion treatments in the dermatological areas of the body
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11857514B2 (en) 2013-03-15 2024-01-02 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
EP3679929A1 (en) * 2013-03-15 2020-07-15 CDA Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
EP3003046B1 (en) * 2013-03-15 2020-07-29 CDA Research Group, Inc. Topical copper ion treatments in the dermatological areas of the body
US10813948B2 (en) 2013-03-15 2020-10-27 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
CN105407726A (zh) * 2013-03-15 2016-03-16 Cda研究集团股份有限公司 身体的皮肤病区域中的局部铜离子治疗物
CN105407886A (zh) * 2013-03-15 2016-03-16 Cda研究集团股份有限公司 局部铜离子治疗物以及制备用于身体不同解剖区域中的局部铜离子治疗物的方法
EP3003046A1 (en) * 2013-03-15 2016-04-13 CDA Research Group, Inc. Topical copper ion treatments in the dermatological areas of the body
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11717535B2 (en) 2013-03-15 2023-08-08 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
WO2014150719A1 (en) 2013-03-15 2014-09-25 Cda Research Group, Inc. Topical copper ion treatments in the dermatological areas of the body
US11298316B2 (en) 2013-03-15 2022-04-12 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
WO2018152614A1 (en) * 2017-02-21 2018-08-30 Fine Cotton Factory Inc. Articles for treating concussion and other disorders
US11459638B2 (en) 2019-02-22 2022-10-04 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Similar Documents

Publication Publication Date Title
ATE506948T1 (de) Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten
HUP0301749A2 (hu) Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
WO2004074444A3 (en) Ferric organic compounds, uses thereof and methods of making same
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
EP2351568A3 (de) Verwendungen von dpp iv Inhibitoren
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
EA200400881A1 (ru) Азаарилпиперазины
ATE344022T1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
JP2009500045A5 (ja)
TW200621732A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
JP2003212765A (ja) 水虫の活動を停止させる溶液
TW200505880A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
TW200508210A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE311866T1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur
ATE445394T1 (de) Verwendung von citrullin zur herstellung eines arzneimittels zur behandlung von ans altern oder an eine bestrahlung gebundener intestinaler insuffizienz
KR960700701A (ko) 파라세타몰 및 l-시스테인 또는 이것의 전구물질을 함유하는 약제조성물(pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof)
ATE422883T1 (de) Verwendung von carnitinen zur prävention und/oder behandlung von krankheiten die durch die andropause verursacht werden
TW200510399A (en) 1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
TW200505830A (en) Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
Pathak et al. A comparison on healing effects of an Ayurvedic preparation and silver sulfadiazine on burn wounds in albino rats
FR2884423B1 (fr) Utilisation de la lecithine comme medicament dans le traitement du psoriasis